Hirotani; Kenji
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hirotani; Kenji.The latest application filed is for "method for selecting individuals to be administered immune checkpoint inhibitor".
- Hirotani; Kenji - Tokyo JP
- Hirotani; Kenji - Chuo-ku Tokyo
| Patent | Date |
|---|---|
| Method for selecting individuals to be administered immune checkpoint inhibitor Grant 11,371,995 - Yonesaka , et al. June 28, 2 | 2022-06-28 |
| Method For Selecting Individuals To Be Administered Immune Checkpoint Inhibitor App 20200173999 - Yonesaka; Kimio ; et al. | 2020-06-04 |
| Method For Treating Egfr-tki-resistant Non-small Cell Lung Cancer By Administration Of Anti-her3 Antibody-drug Conjugate App 20200061031 - YONESAKA; Kimio ; et al. | 2020-02-27 |
| Anti B7-h3 Antibody App 20160368990 - Takahashi; Shu ; et al. | 2016-12-22 |
| Anti B7-H3 antibody Grant 9,371,395 - Takahashi , et al. June 21, 2 | 2016-06-21 |
| Anti B7-h3 Antibody App 20130078234 - Takahashi; Shu ; et al. | 2013-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 